<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "../dtd/journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en">
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher-id">JRI</journal-id>
			<journal-title>Journal of Reproduction and Infertility</journal-title>
			<issn pub-type="ppub">2228-5482</issn>
			<issn pub-type="epub">2251-676X</issn>
			<publisher>
				<publisher-name>Avicenna Research Institute</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="publisher-id">JRI-10-193</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Original Article</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Producing Recombinant mTEX101; a Murine Testis Specific Protein</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Barzegar Yarmohammadi</surname>
						<given-names>Leila</given-names>
					</name>
					<degrees>M.Sc</degrees>
					<xref ref-type="aff" rid="AF0001">1</xref>
					<xref ref-type="aff" rid="AF0002">2</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Modarresi</surname>
						<given-names>Mohammad Hossein</given-names>
					</name>
					<degrees>Ph.D</degrees>
					<xref ref-type="aff" rid="AF0002">2</xref>
					<xref ref-type="aff" rid="AF0003">3</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Talebi</surname>
						<given-names>Saeed</given-names>
					</name>
					<degrees>M.D</degrees>
					<xref ref-type="aff" rid="AF0001">1</xref>
					<xref ref-type="aff" rid="AF0002">2</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Hadavi</surname>
						<given-names>Reza</given-names>
					</name>
					<degrees>M.Sc</degrees>
					<xref ref-type="aff" rid="AF0001">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Ostad Karampour</surname>
						<given-names>Mahyar</given-names>
					</name>
					<degrees>M.Sc</degrees>
					<xref ref-type="aff" rid="AF0001">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Mahmoudi</surname>
						<given-names>Ahmad Reza</given-names>
					</name>
					<degrees>M.Sc</degrees>
					<xref ref-type="aff" rid="AF0001">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Akhondi</surname>
						<given-names>Mohammad Mehdi</given-names>
					</name>
					<degrees>Ph.D</degrees>
					<xref ref-type="aff" rid="AF0004">4</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Rabbani</surname>
						<given-names>Hodjattallah</given-names>
					</name>
					<degrees>Ph.D</degrees>
					<xref ref-type="aff" rid="AF0001">1</xref>
					<xref ref-type="aff" rid="AF0005">5</xref>
				</contrib>
				<contrib contrib-type="author" corresp="yes">
					<name>
						<surname>Jeddi-Tehrani</surname>
						<given-names>Mahmood</given-names>
					</name>
					<degrees>Ph.D</degrees>
					<xref ref-type="aff" rid="AF0001">1</xref>
					<xref ref-type="aff" rid="AF0005">5</xref>
					<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
				</contrib>
			</contrib-group>
			<aff id="AF0001">
				<label>1</label>Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</aff>
			<aff id="AF0002">
				<label>2</label>Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</aff>
			<aff id="AF0003">
				<label>3</label>Pasteur Institute of Iran, Tehran, Iran</aff>
			<aff id="AF0004">
				<label>4</label>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</aff>
			<aff id="AF0005">
				<label>5</label>Immune and Gene Therapy Laboratory, Karolinska Cancer Center, Karolinska University Hospital, Stockholm, Sweden</aff>
			<author-notes>
				<corresp id="cor1">
				<label>&#x002A;</label>
				<italic>Corresponding Author:</italic> Dr. Mahmood Jeddi-Tehrani, Monoclonal Antibody Research Center, Avicenna Research Institute, Shahid Beheshti University, Velenjak, P.O. Box: 19615-1177, Tehran, Iran. <italic>E-mail:</italic> <email xlink:href="mahjed@yahoo.com">mahjed@yahoo.com</email>, <email xlink:href="mahjed@avicenna.ac.ir">mahjed@avicenna.ac.ir</email>
				</corresp>
			</author-notes>
			<pub-date pub-type="ppub">
				<season>Oct-Dec</season>
				<year>2009</year>
			</pub-date>
			<volume>10</volume>
			<issue>3</issue>
			<fpage>193</fpage>
			<lpage>198</lpage>
			<history>
				<date date-type="received">
					<day>03</day>
					<month>02</month>
					<year>2009</year>
				</date>
				<date date-type="accepted">
					<day>15</day>
					<month>06</month>
					<year>2009</year>
				</date>
			</history>
			<permissions>
				<copyright-statement>Copyright &#x00A9; 2009 Avicenna Research Institute</copyright-statement>
				<copyright-year>2009</copyright-year>
				<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
					<p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</p>
				</license>
			</permissions>
			<abstract>
				<sec id="st1">
					<title>Introduction</title>
					<p>Production of antibodies against specific proteins of testis germ cells is of great significance for the investigation of processes involved in spermatogenesis, study of infertility problems and determination of the probable role of these proteins as cancer-testis antigens. Murine Testis Specific Recombinant Protein 101 (mTEX101) is a 38<italic>kDa</italic>, GPI-anchored protein which is expressed in testis germ cells of adult mice but it seems to be absent in other tissues. The structure and function of mTEX101 is not completely understood yet, but it is speculated that it may transduce biochemical signals into the cytoplasm since mTEX101 does not have an intracellular domain but the precise mechanisms are still ambiguous.</p>
				</sec>
					<sec id="st2">
					<title>Materials and Methods</title>
					<p>RNA was extracted from three adult mice testis. The RNA was used in RT-PCR, employing a pair of specific primers for mTEX101 ORF region. TA-cloning technique was performed by the insertion of mTEX101 into a pGEM-T Easy Vector, followed by its subcloning into a His-tagged expression vector, pET-28a (+). The recombinant mTEX101 was then produced by transfection of the expression vector into BL 21 (DE3) E. coli strain.</p>
				</sec>
					<sec id="st3">
					<title>Results</title>
					<p>A recombinant protein, weighing 27<italic>kDa</italic>, was produced upon IPTG-induction of the bacterial host. The presence of mTEX101 protein was detected through Western blot analysis by anti-mTEX101 peptide antibodies.</p>
					</sec>
					<sec id="st4">
					<title>Conclusion</title>
					<p>We produced mTEX101 recombinant protein that could be used for the production of mono and polyclonal antibodies.</p>
				</sec>
			</abstract>
			<kwd-group>
				<kwd>Antibody production</kwd>
				<kwd>Gametogenesis</kwd>
				<kwd>Germ cell</kwd>
				<kwd>Glycoprotein</kwd>
				<kwd>Recombinant protein</kwd>
				<kwd>Spermatogenesis</kwd>
				<kwd>TES101 protein mouse</kwd>
				<kwd>Testis</kwd>
			</kwd-group>
		</article-meta>
		<notes>
		<p><bold>To cite this article:</bold> Barzegar Yarmohammadi L, Modarresi MH, Talebi S, Hadavi R, Ostad Karampour M, Mahmoudi AR, et al. Producing Recombinant mTEX101; a Murine Testis Specific Protein. J Reprod Infertil. 2009;10(3):193-8.</p>
		</notes>
	</front>
	<body>
		<sec id="S0001" sec-type="intro">
			<title>Introduction</title>
			<p>Spermatogenesis is a complex process of development that occurs in most mammals throughout adulthood period. This process happens in seminiferous tubules, lined with epithelial tissue that contains Sertoli cells. Sertoli cells are surrounded by a thin septum of peritubular cells that hold keep germ cells (<xref ref-type="bibr" rid="CIT0001">1</xref>, <xref ref-type="bibr" rid="CIT0002">2</xref>).</p>
			<p>The spermatogonia undergo mitotic divisions, meiotic alternations, and morphologically transform to highly developed cells, spermatozoa, with a unique function and structure (<xref ref-type="bibr" rid="CIT0003">3</xref>). Such a complex process needs a unique program to control and regulate the involved genes. This gene regulation is accomplished by cell surface molecules which participate in cell to cell and cell to extracellular matrix interactions (<xref ref-type="bibr" rid="CIT0004">4</xref>, <xref ref-type="bibr" rid="CIT0005">5</xref>). On the other hand, when sperm is passing through the male and female genital tracts, it gains fertilization ability (Capacitation) and adopts maturity characteristics. Maturity is initiated in the epididymis, where sperm communicates with the cell surface molecules of the pathway (<xref ref-type="bibr" rid="CIT0006">6</xref>). Therefore, the investigation of stage and/or cell-specific molecular expression in testis or post-testicular maturation system can improve our understanding of germ cell differentiation and sperm formation (<xref ref-type="bibr" rid="CIT0007">7</xref>).</p>
			<p>Kurita <italic>et al</italic>. first identified a 38<italic>kDa</italic> protein (mTEX101) in adult mouse testis which is detectable on the surface of spermatocytes and spermatids in testis that it is absent on somatic cells, including Sertoli or interstitial cells, like Leydig cells (<xref ref-type="bibr" rid="CIT0003">3</xref>). MTEX101 shows sexually dimorphic expression during gametogenesis. In the developing ovary, there is a temporary expression of mTEX101 on oogonia, but the molecule disappears in the mature ovary. In embryonic testis, mTEX101 is detected on the prosperm-atogonia (<xref ref-type="bibr" rid="CIT0008">8</xref>). Upon puberty, mTEX101 mRNA is expressed in spermatocytes and in steps 1-9 spermatids during spermatogenesis, but not during spermatogonia. The TEX101 protein remains on the cell surfaces in steps 10-16 spermatids and testicular sperm, but hides from epididymal sperm after passing the caput epididymis (<xref ref-type="bibr" rid="CIT0006">6</xref>).</p>
			<p>MTEX101 homologues have been identified in rats and humans. Aside from testis, the expression of mTEX101 homologous protein has been reported in a leukemia cell line and lung cancer in rats and humans, respectively (<xref ref-type="bibr" rid="CIT0009">9</xref>, <xref ref-type="bibr" rid="CIT0010">10</xref>).</p>
			<p>The exact structure and function of mTEX101 is not completely understood yet, but it has been speculated that this protein is associated with several transmembrane proteins like Ly6<italic>k</italic>
			 (<xref ref-type="bibr" rid="CIT0011">11</xref>) and Cellubrevin (<xref ref-type="bibr" rid="CIT0012">12</xref>) that transduce the extra-cellular signals to the intracellular molecules. The present study was undertaken to produce recombinant mTEX101, which might pave the way for the production of specific antibodies for further structural and functional characterization of the molecule.</p>
		</sec>
		<sec id="S0002" sec-type="materials|methods">
			<title>Materials and Methods</title>
			<sec id="S20003">
				<title>RT PCR</title>
				<p>Total RNA was isolated from male gonadal organs (four to 6 week-old mice from Pasteur Institute of Iran). RNA concentration was measured by a BioPhotometer (Eppendorf, Hamburg, Germany) at 260<italic>nm</italic>. One microgram of the total RNA was reversetranscribed to cDNA by using 200<italic>U</italic> of Molony Murine Leukemia Virus (RTM-MULV) reverse transcriptase enzyme (Fermentas, Vilnius, Lithuania), and 20<italic>pmol</italic> of random hexamer primers (Cybergene, Stockholm, Sweden). PCR amplifications for mTEX101 transcript was performed in a volume of 25<italic>&#x00B5;l</italic> using 10-20<italic>ng</italic> of testis cDNA, forward and reverse primers (10<italic>pmol</italic> each), specific for mTEX101 transcript, 10X PCR buffer (2.5<italic>&#x00B5;l</italic>), dNTP mixture (0.2<italic>mM</italic> each), 1<italic>mM</italic> MgCl2, and 1 unit of Taq DNA polymerase (Roche, Mannheim, Germany). PCR oligonucleotide primers were designed based on the mTEX101 ORF. Optimization of temperature and MgCl2 were performed to obtain a high quality PCR product. The best result was observed at 60<italic>&#x00B0;C</italic> with 1<italic>mM</italic> MgCl2. PCR reactions were carried out using a thermal cycler (Eppendorf Mastercycler Gradient) as indicated below: a preheating cycle at 95<italic>&#x00B0;C</italic> for 3min, 35 cycles of denaturation at 95<italic>&#x00B0;C</italic> for 30sec, annealing at 60<italic>&#x00B0;C</italic> for 30<italic>sec</italic>, extension at 72<italic>&#x00B0;C</italic> for 60<italic>sec</italic>, and finally a 7-min cycle at 72<italic>&#x00B0;C</italic>. The forward and reverse mTEX101 ORF primers used (Forward: 5&#x2032;CCG AAT TCA TGG GAG CCT GCC GCA TCC AG 3&#x2032;, Reverse: 5&#x2032; AGG GAA GTG GGT GAG GGG GGA GCA GAG CGG CCG C 3&#x2032;.), contained EcoRI and NotI restriction enzyme (RE) sites, respectively.</p>
				<p>The PCR products were resolved by ethidium bromide-stained 1.5% agarose gel electrophoresis, which revealed a single distinct band at 750<italic>bp</italic> (<xref ref-type="fig" rid="F0001">Figure 1</xref>). The 750<italic>bp</italic> band was purified using QIA quick Gel Extraction Kit (QIAGEN, Germantown, MD, USA).</p>
				<fig id="F0001">
					<label>Figure 1</label>
					<caption>
						<p>PCR optimization on mouse testis cDNA by MgCl2 gradients. 1-4: MgCl2 concentrations from 1 to 4 mM, respectively, 5: 1<italic>Kb</italic> DNA ladder, 6: negative control (no DNA).</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JRI-10-193-g001.tif" alt-version="no"/>
				</fig>
			</sec>
			<sec id="S20004">
				<title>Cloning of mTEX101 in TA vector</title>
				<p>The pGEM-T Easy Vector (Promega, Madison, WI, USA) was used for the cloning of the purified PCR product. Ligation reac tion was set up by 50<italic>ng</italic> of pGEM-T Easy Vector (Promega), three units of T4 DNA ligase, 75<italic>ng</italic> of mTEX101 purified fragment, and 6<italic>&#x00B5;l</italic> of Rapid 2X Ligation Buffer (Promega). The mixture was incubated at 16<italic>&#x00B0;C</italic> for 16<italic>hrs</italic>. Competent cells of E. coli JM109 strain were used for transformation through heat shock method (<xref ref-type="bibr" rid="CIT0017">17</xref>). The transformed bacteria were left for 1 hr in LB broth at 37<italic>&#x00B0;C</italic> for recovery, and later 100<italic>&#x00B5;l</italic> of the transformation culture was plated onto an ampicillin (100<italic>mg/ml</italic>) (Sigma, Louis, MO, USA), IPTG (Sigma) (0.5<italic>mM</italic>) and X-gal (Sigma), (80<italic>&#x00B5;g/ml</italic>) containing LB agar plate and was cultured for 16<italic>hrs</italic> at 37<italic>&#x00B0;C</italic>.</p>
				<p>White colonies were screened by 25 cycles of colony PCR under the aforementioned conditions. The recombinant plasmids were isolated from confirmed colonies by miniperp kit (QIAGEN) and then digested by EcoRI and NotI restriction enzymes. Plasmid DNA (800<italic>ng</italic>) was used in 25<italic>&#x00B5;l</italic> of the total volume, including NotI (15units), (Invitrogen, Carlsbad, CA, USA), EcoRI (15 units), (Invitrogen), and 2.5<italic>&#x00B5;l</italic> of 10 X Reaction buffer 3 (Invitrogen) and incubated for 1.5 hr at 37<italic>&#x00B0;C</italic>. The mTEX101 fragment in pGEM-T Easy was extracted form agarose gel and then subcloned into a pET-28a (+) expression vector (Merck, Darmstadt, Germany) and was digested by the same restriction enzymes above. Ligation reaction was performed by 125<italic>ng</italic> of digested pET-28a (+), 0.5<italic>pmol</italic> of mTEX101 purified fragment<italic>s</italic>, 2<italic>&#x00B5;l</italic> of Rapid 2X ligation buffer (Pro-mega), and 3 units of T4 DNA ligase (Promega) in 10<italic>&#x00B5;l</italic> of the total volume and it was incubated overnight at 4<italic>&#x00B0;C</italic>. Ligation products were used for transformation of E. coli JM109 strain by heat shock method (<xref ref-type="bibr" rid="CIT0017">17</xref>). After a recovery time of 1 hour in LB broth, the transformed bacteria were cultured on LB agar and Kanamycin (50<italic>&#x00B5;g/ml</italic>) (Sigma, USA) containing plates for 16 hrs at 37<italic>&#x00B0;C</italic>. The obtained colonies were screened by colony PCR and one of them was confirmed by DNA sequencing. Recombinant plasmid was purified and was then used for transformation of BL21 (DE3), which is a protease deficient strain of E. coli.</p>
			</sec>
			<sec id="S20005">
				<title>Recombinant protein production</title>
				<p>A single transformed colony was inoculated into 50<italic>ml</italic> of LB broth, including Kanamycin (50<italic>&#x00B5;g/ml</italic>) (Sigma, USA) and untransformed BL21 (DE3) bacteria were cultured into 50 ml of LB medium. Incubation was performed under shaking at 37<italic>&#x00B0;C</italic> until the optical density (OD) at 600<italic>nm</italic> reached 0.6. Ten milliliters of each sample was removed as an uninduced control. IPTG (Sigma) was added to the remainder with the final concentration of 1<italic>mM</italic> and incubation continued for 2-3 more hours. The cells were harvested by centrifugation at 5000<italic>g</italic> for 5<italic>min</italic> at 4<italic>&#x00B0;C</italic>. Cell lysates were prepared by sonication of pellets in PBS buffer including 1% protease inhibitor (Roche).</p>
			</sec>
			<sec id="S20006">
				<title>Immunoblotting</title>
				<p>Protein concentration of the cell lysates were determined by Bradford Protein Assay. Protein solutions were obtained from bacteria by boiling them in a sample buffer that contained Tris-HCl (pH=6.8, 0.5<italic>M</italic>), SDS (10% W/V), Glycerol (50% V/V), and Bromo Phenol Blue (0.5% W/V), for 5min. Samples (50<italic>&#x00B5;l</italic> of each) were separated by SDS-PAGE (8%) (Bio-Rad, Hercules, CA, USA) under non-reducing conditions. Untransformed and uninduced bacteria were used as negative controls.</p>
				<p>The protein constituents were then electro-phoretically blotted onto a polyvinylidene difluoride (PVDF) membrane (Millipore, Billerica, MA, USA), as described by Towbin <italic>et al</italic>.
				 (<xref ref-type="bibr" rid="CIT0013">13</xref>). The membrane was blocked in 5% skim milk / 0.1% Tween 20 in PBS (pH 7.4), and then the reactivity of the transferred protein(s) with 1<italic>&#x00B5;g/ml</italic> of anti mTEX101 pAb (Avicenna Research Institute, Iran) was assessed using sheep anti rabbit Ig HRP (Avicenna Research Institute, Iran). Finally, the membranes were visualized using an ECL system (GE Healthcare, Biotech, Bucking-hamshire, UK).</p>
			</sec>
		</sec>
		<sec id="S0007" sec-type="results">
			<title>Results</title>
			<sec id="S20008">
				<title>mTEX101 Cloning</title>
				<p>After cloning mTEX101 fragments in pGEM-T Easy Vector, several white colonies with probable target fragment inclusion were screened by colony PCR (<xref ref-type="fig" rid="F0002">Figure 2</xref>). A right-sized PCR product and a pET-28a(+) vector were cut by NotI and EcoRI restriction enzymes to obtain the required fragments for the next step (<xref ref-type="fig" rid="F0003">Figures 3</xref> and <xref ref-type="fig" rid="F0004">4</xref>).</p>
				<fig id="F0002">
					<label>Figure 2</label>
					<caption>
						<p>Coloy PCR on transformed JM109 clones by pGEM-T Easy vector carrying mTEX101 gene. 1-5: 5 selected white colonies, 6: negative control (blue colony), 7: positive control (PCR product on testis cDNA), 8: DNA ladder VIII (Roche).</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JRI-10-193-g002.tif" alt-version="no"/>
				</fig>
				<fig id="F0003">
					<label>Figure 3</label>
					<caption>
						<p>Double digestion of pGEM-T easy vector containing mTEX101 fragment with EcoRI and NotI restriction enzymes. 1: digested vector with mTEX101 750<italic>bp</italic> insert cut out of the vector, 2: DNA ladder VIII.</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JRI-10-193-g003.tif" alt-version="no"/>
				</fig>
				<fig id="F0004">
					<label>Figure 4</label>
					<caption>
						<p>Double digestion of pET-28a (+) expression vector with restriction enzymes. 1: digested pET-28a (+) with EcoRI and NotI, 2: uncut pET-28a (+), 3: 1<italic>Kb</italic> DNA ladder.</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JRI-10-193-g004.tif" alt-version="no"/>
				</fig>
				<p>E. coli J M109 strains were transformed using recombinant pET-28a(+) containing mTEX101 fragment and the undertaken transformation was verified by colony PCR (<xref ref-type="fig" rid="F0005">Figure 5</xref>). One of the confirmed colonies (clone 2 in <xref ref-type="fig" rid="F0005">Figure 5</xref>) was picked for detailed analysis by DNA sequencing. Alignment of DNA sequencing results with mTEX101 ORF by Genbee site (<xref ref-type="bibr" rid="CIT0014">14</xref>) confirmed the cloned sequence. The verified fragment was used for the next round of transformation using E-coli BL21 (DE3) strain.</p>
				<fig id="F0005">
					<label>Figure 5</label>
					<caption>
						<p>Colony PCR on transformed JM109 clones by pET-28a (+) vector containing mTEX101 fragment. 1 and 2 represent two selected colonies, 3: DNA ladder VIII, 4: negative control (no DNA), 5: positive control (pGEM-T Easy vector containing mTEX101 fragment).</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JRI-10-193-g005.tif" alt-version="no"/>
				</fig>
			</sec>
			<sec id="S20009">
				<title>Immunoblotting</title>
				<p>Western blot analysis using anti-mTE X 101 peptide polyclonal antibody revealed the correct size of mTEX101 recombinant protein production (27<italic>kDa</italic>) in BL-21 (DE3) bacteria (<xref ref-type="fig" rid="F0006">Figure 6</xref>).</p>
				<fig id="F0006">
					<label>Figure 6</label>
					<caption>
						<p>Western blot analysis of production of the recombinant mTEX101 in BL21 (DE3) bacteria. 1: BL21 (DE3) containing mTEX101 gene after induction, 2: BL21 (DE3) containing mTEX101 gene before induction, 3: Untransfected BL21 (DE3), 4: Protein marker (See Blue-Invitrogen).</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JRI-10-193-g006.tif" alt-version="no"/>
				</fig>
			</sec>
		</sec>
		<sec id="S0010" sec-type="discussion">
			<title>Discussion</title>
			<p>MTEX101 was first reported and characterized by Kurita <italic>et al</italic>. in 2001 (<xref ref-type="bibr" rid="CIT0003">3</xref>). The researchers immunized female mice with 8-week old testis lysates and obtained 12 monoclonal antibody producing clones (TES101-112). Immunohisto-chemistry analyses revealed that only TES101 was able to recognize a novel testicular protein as determined by searching the Expressed Sequence Tag (EST) database (<xref ref-type="bibr" rid="CIT0003">3</xref>). All studies on mTEX101 protein are performed solely by TES101 antibody and presently, no commercial antibodies are available to carry out research on this protein. In this study, we produced mTEX101 recombinant protein that is useful for antibody development for further investigations.</p>
			<p>MTEX101 mRNA contains 750 bases, which encodes 250 amino acids. After the removal of the putative 25-amino acid signal peptide at N-terminus, the molecular mass of the remaining protein is expected to be about 24<italic>kDa</italic>. Kurita <italic>et al</italic>. reported a 38<italic>kDa</italic> band by Western blot analysis under non-reducing conditions and no 24 kDa band was observed (<xref ref-type="bibr" rid="CIT0003">3</xref>). This large difference in the molecular mass was speculated to be due to glycosylation of the peptide and it was proved to be true by Jin <italic>et al</italic>. observations (<xref ref-type="bibr" rid="CIT0015">15</xref>).</p>
			<p>Glycosylation is known as the prime cause of post-translational modifications (PTM) in proteins (<xref ref-type="bibr" rid="CIT0016">16</xref>). The Asn-X-Ser/Thr is the basic sequence for N-linked glycosylation, however, the secondary structure of the protein can affect the final addition. No consensus sequence has been established for O-linked glycosylation yet (<xref ref-type="bibr" rid="CIT0017">17</xref>).</p>
			<p>Jin et al, found four putative sites for N-glyco-sylation and several possible sites for O-glyco-sylation in mTEX101 amino acid sequence (<xref ref-type="bibr" rid="CIT0015">15</xref>). In fact, mTEX101 is a highly glycosylated protein and it has been clarified that most of the oligosaccharide chains on this peptide are N-linked carbohydrates (<xref ref-type="bibr" rid="CIT0012">12</xref>). De-N-glycosylation of mTEX101 created an &#x223C;20<italic>kDa</italic> band which is close to or even smaller than estimated molecular weight of mTEX101 amino acid backbone (<xref ref-type="bibr" rid="CIT0015">15</xref>), confirming glycosylation as the cause for the higher mass of native mTEX101.</p>
			<p>The cellular role of glycoprotein sugar components can be investigated via several methods, like protein production in a host lacking oligo-saccharide addition system, such as prokaryotes (<xref ref-type="bibr" rid="CIT0018">18</xref>). We succeeded to produce mTEX101 recombinant protein in a prokaryotic system, which may be useful in clarifying the role of sugar components in protein structures. However, proteins which are produced by this method may vary in their structures and functions (<xref ref-type="bibr" rid="CIT0019">19</xref>). Western blot analysis showed that this protein had a molecular mass of approximately 27<italic>kDa</italic> under non-reducing conditions that is concordant with the various post-translational modification processes in prokaryotic systems as compared to those in eukaryotes. The size of the recombinant protein (27<italic>kDa</italic>) is in conformity with the backbone protein (24<italic>kDa</italic>) and a 3<italic>kDa</italic> peptide derived from the digested vector by NotI and EcoRI restriction enzymes.</p>
		</sec>
		<sec id="S0011" sec-type="conclusion">
			<title>Conclusion</title>
			<p>In this study, we successfully cloned mTEX101 into a His-tagged expression vector (pET-28a(+)), followed by an efficient production of the relevant recombinant protein. This protein can be used in antibody production to find out the role of mTEX101 in spermatogenesis, egg fertilization and further investigation about the critical role of glycosylation in the function of this protein.</p>
		</sec>
	</body>
	<back>
		<ack>
			<title>Acknowledgement</title>
			<p>We are deeply grateful to Mrs. R. Ghods, from Avicenna Research Institute, for her encouragements throughout the course of this study. This work was supported by a grant (number:957-33) from Avicenna Research Institute.</p>
		</ack>
		<ref-list>
			<title>References</title>
			<ref id="CIT0001">
				<label>1</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Mackay</surname>
							<given-names>S</given-names>
						</name>
					</person-group>
					<article-title>Gonadal development in mammals at the cellular and molecular levels</article-title>
					<source>Int Rev Cytol.</source>
					<year>2000</year>
					<volume>200</volume>
					<fpage>47</fpage>
					<lpage>99</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0002">
				<label>2</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Starz-Gaiano</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Lehmann</surname>
							<given-names>R</given-names>
						</name>
					</person-group>
					<article-title>Moving towards the next generation</article-title>
					<source>Mech Dev.</source>
					<year>2001</year>
					<volume>105</volume>
					<issue>1-2</issue>
					<fpage>5</fpage>
					<lpage>18</lpage>
					<comment>Review</comment>
				</nlm-citation>
			</ref>
			<ref id="CIT0003">
				<label>3</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Kurita</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Takizawa</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Takayama</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Totsukawa</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Matsubara</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Shibahara</surname>
							<given-names>H</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Identification, cloning, and initial characterization of a novel mouse testicular germ cell-specific antigen</article-title>
					<source>Biol Reprod.</source>
					<year>2001</year>
					<volume>64</volume>
					<issue>3</issue>
					<fpage>935</fpage>
					<lpage>45</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0004">
				<label>4</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Fujisawa</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>Cell-to-cell cross talk in the testis</article-title>
					<source>Urol Res.</source>
					<year>2001</year>
					<volume>29</volume>
					<issue>3</issue>
					<fpage>144</fpage>
					<lpage>51</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0005">
				<label>5</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Siu</surname>
							<given-names>MK</given-names>
						</name>
						<name>
							<surname>Cheng</surname>
							<given-names>CY</given-names>
						</name>
					</person-group>
					<article-title>Dynamic cross-talk between cells and the extracellular matrix in the testis</article-title>
					<source>Bioessays.</source>
					<year>2004</year>
					<volume>26</volume>
					<issue>9</issue>
					<fpage>978</fpage>
					<lpage>92</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0006">
				<label>6</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Dacheux</surname>
							<given-names>JL</given-names>
						</name>
						<name>
							<surname>Gatti</surname>
							<given-names>JL</given-names>
						</name>
						<name>
							<surname>Dacheux</surname>
							<given-names>F</given-names>
						</name>
					</person-group>
					<article-title>Contribution of epididymal secretory proteins for spermatozoa maturation</article-title>
					<source>Microsc Res Tech.</source>
					<year>2003</year>
					<volume>61</volume>
					<issue>1</issue>
					<fpage>7</fpage>
					<lpage>17</lpage>
					<comment>Review</comment>
				</nlm-citation>
			</ref>
			<ref id="CIT0007">
				<label>7</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Takayama</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Mishima</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Mori</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Ishikawa</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Takizawa</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Goto</surname>
							<given-names>T</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>TEX101 is shed from the surface of sperm located in the caput epididymidis of the mouse</article-title>
					<source>Zygote.</source>
					<year>2005</year>
					<volume>13</volume>
					<issue>4</issue>
					<fpage>325</fpage>
					<lpage>33</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0008">
				<label>8</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Takayama</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Mishima</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Mori</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Jin</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Tsukamoto</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Takahashi</surname>
							<given-names>K</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Sexually dimorphic expression of the novel germ cell antigen TEX101 during mouse gonad development</article-title>
					<source>Biol Reprod.</source>
					<year>2005</year>
					<volume>72</volume>
					<issue>6</issue>
					<fpage>1315</fpage>
					<lpage>23</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0009">
				<label>9</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>H&#x00E1;lov&#x00E1;</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Dr&#x00E1;berov&#x00E1;</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Dr&#x00E1;ber</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<article-title>A novel lipid raft-associated glycoprotein, TEC-21, activates rat baso-philic leukemia cells independently of the type 1 Fc epsilon receptor</article-title>
					<source>Int Immunol.</source>
					<year>2002</year>
					<volume>14</volume>
					<issue>2</issue>
					<fpage>213</fpage>
					<lpage>23</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0010">
				<label>10</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Tajima</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Obata</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Tamaki</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Yoshida</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>YT</given-names>
						</name>
						<name>
							<surname>Scanlan</surname>
							<given-names>MJ</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Expression of cancer/testis (CT) antigens in lung cancer</article-title>
					<source>Lung Cancer.</source>
					<year>2003</year>
					<volume>42</volume>
					<issue>1</issue>
					<fpage>23</fpage>
					<lpage>33</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0011">
				<label>11</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Yoshitake</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Tsukamoto</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Maruyama-Fukushima</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Takamori</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Ogawa</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Araki</surname>
							<given-names>Y</given-names>
						</name>
					</person-group>
					<article-title>TEX101, a germ cell-marker glycoprotein, is associated with lymphocyte antigen 6 complex locus k within the mouse testis</article-title>
					<source>Biochem Biophys Res Commun.</source>
					<year>2008</year>
					<volume>372</volume>
					<issue>2</issue>
					<fpage>277</fpage>
					<lpage>82</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0012">
				<label>12</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Tsukamoto</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Yoshitake</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Mori</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Yanagida</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Takamori</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Ogawa</surname>
							<given-names>H</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Testicular proteins associated with the germ cell-marker, TEX101: involvement of cellubrevin in TEX101-trafficking to the cell surface during spermatogenesis</article-title>
					<source>Bio-chem Biophys Res Commun.</source>
					<year>2006</year>
					<volume>345</volume>
					<issue>1</issue>
					<fpage>229</fpage>
					<lpage>38</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0013">
				<label>13</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Towbin</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Staehelin</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Gordon</surname>
							<given-names>J</given-names>
						</name>
					</person-group>
					<article-title>Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications</article-title>
					<source>Proc Natl Acad Sci USA.</source>
					<year>1979</year>
					<volume>76</volume>
					<issue>9</issue>
					<fpage>4350</fpage>
					<lpage>4</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0014">
				<label>14</label>
				<nlm-citation citation-type="web">
					<collab>GeneBee [internet]</collab>
					<article-title>GeneBee - Molecular Biology Server</article-title>
					<publisher-loc>Moscow</publisher-loc>
					<publisher-name>A.N. Belozersky Institute of Physico-Chemical Biology</publisher-name>
					<fpage>1965</fpage>
					<lpage>2009</lpage>
					<comment>2008 Dec 20 [cited Dec 25]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.genebee.msu.su/services/malign_reduced.html">http://www.genebee.msu.su/services/malign_reduced.html</ext-link>
					</comment>
				</nlm-citation>
			</ref>
			<ref id="CIT0015">
				<label>15</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Jin</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Yoshitake</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Tsukamoto</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Takahashi</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Mori</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Takizawa</surname>
							<given-names>T</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Molecular characterization of a germ-cell-specific antigen, TEX101, from mouse testis</article-title>
					<source>Zygote.</source>
					<year>2006</year>
					<volume>14</volume>
					<issue>3</issue>
					<fpage>201</fpage>
					<lpage>8</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0016">
				<label>16</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Campbell</surname>
							<given-names>CT</given-names>
						</name>
						<name>
							<surname>Yarema</surname>
							<given-names>KJ</given-names>
						</name>
					</person-group>
					<article-title>Large-scale approaches for glycobiology</article-title>
					<source>Genome Biol.</source>
					<year>2005</year>
					<volume>6</volume>
					<issue>11</issue>
					<fpage>236</fpage>
					<comment>Review</comment>
				</nlm-citation>
			</ref>
			<ref id="CIT0017">
				<label>17</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Hang</surname>
							<given-names>HC</given-names>
						</name>
						<name>
							<surname>Bertozzi</surname>
							<given-names>CR</given-names>
						</name>
					</person-group>
					<article-title>The chemistry and biology of mucin-type O-linked glycosylation</article-title>
					<source>Bioorg Med Chem.</source>
					<year>2005</year>
					<volume>13</volume>
					<issue>17</issue>
					<fpage>5021</fpage>
					<lpage>34</lpage>
					<comment>Review</comment>
				</nlm-citation>
			</ref>
			<ref id="CIT0018">
				<label>18</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Shriver</surname>
							<given-names>Z</given-names>
						</name>
						<name>
							<surname>Raguram</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Sasisekharan</surname>
							<given-names>R</given-names>
						</name>
					</person-group>
					<article-title>Glycomics: a pathway to a class of new and improved therapeutics</article-title>
					<source>Nat Rev Drug Discov.</source>
					<year>2004</year>
					<volume>3</volume>
					<issue>10</issue>
					<fpage>863</fpage>
					<lpage>73</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0019">
				<label>19</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Walsh</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Jefferis</surname>
							<given-names>R</given-names>
						</name>
					</person-group>
					<article-title>Post-translational modifications in the context of therapeutic proteins</article-title>
					<source>Nat Biotechnol.</source>
					<year>2006</year>
					<volume>24</volume>
					<issue>10</issue>
					<fpage>1241</fpage>
					<lpage>52</lpage>
					<comment>Review</comment>
				</nlm-citation>
			</ref>
		</ref-list>
	</back>
</article>
